These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24909495)

  • 1. Cancer cell metabolism and developmental homeodomain/POU domain transcription factors: a connecting link.
    Purkayastha BP; Roy JK
    Cancer Lett; 2015 Jan; 356(2 Pt A):315-9. PubMed ID: 24909495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose metabolism and cancer.
    Shaw RJ
    Curr Opin Cell Biol; 2006 Dec; 18(6):598-608. PubMed ID: 17046224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MYC-induced cancer cell energy metabolism and therapeutic opportunities.
    Dang CV; Le A; Gao P
    Clin Cancer Res; 2009 Nov; 15(21):6479-83. PubMed ID: 19861459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of multifaceted regulators in cancer glucose metabolism and their clinical significance.
    Zhao L; Mao Y; Zhao Y; Cao Y; Chen X
    Oncotarget; 2016 May; 7(21):31572-85. PubMed ID: 26934324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-induced metabolic shifts in cancer cells: moving beyond the Warburg effect.
    Weljie AM; Jirik FR
    Int J Biochem Cell Biol; 2011 Jul; 43(7):981-9. PubMed ID: 20797448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PKM2 contributes to cancer metabolism.
    Wong N; Ojo D; Yan J; Tang D
    Cancer Lett; 2015 Jan; 356(2 Pt A):184-91. PubMed ID: 24508027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic adaptation to cancer growth: from the cell to the organism.
    Escoté X; Fajas L
    Cancer Lett; 2015 Jan; 356(2 Pt A):171-5. PubMed ID: 24709629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional Regulation of the Warburg Effect in Cancer by SIX1.
    Li L; Liang Y; Kang L; Liu Y; Gao S; Chen S; Li Y; You W; Dong Q; Hong T; Yan Z; Jin S; Wang T; Zhao W; Mai H; Huang J; Han X; Ji Q; Song Q; Yang C; Zhao S; Xu X; Ye Q
    Cancer Cell; 2018 Mar; 33(3):368-385.e7. PubMed ID: 29455928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells.
    Wang P; Branch DR; Bali M; Schultz GA; Goss PE; Jin T
    Biochem J; 2003 Oct; 375(Pt 1):199-205. PubMed ID: 12841847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells.
    Mazurek S
    Int J Biochem Cell Biol; 2011 Jul; 43(7):969-80. PubMed ID: 20156581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. POU domain transcription factors: BRN2 as a regulator of melanocytic growth and tumourigenesis.
    Cook AL; Sturm RA
    Pigment Cell Melanoma Res; 2008 Dec; 21(6):611-26. PubMed ID: 18983536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth.
    Zhao YH; Zhou M; Liu H; Ding Y; Khong HT; Yu D; Fodstad O; Tan M
    Oncogene; 2009 Oct; 28(42):3689-701. PubMed ID: 19668225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer.
    Yalcin A; Telang S; Clem B; Chesney J
    Exp Mol Pathol; 2009 Jun; 86(3):174-9. PubMed ID: 19454274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How the Warburg effect supports aggressiveness and drug resistance of cancer cells?
    Icard P; Shulman S; Farhat D; Steyaert JM; Alifano M; Lincet H
    Drug Resist Updat; 2018 May; 38():1-11. PubMed ID: 29857814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function.
    Martinez-Outschoorn U; Sotgia F; Lisanti MP
    Semin Oncol; 2014 Apr; 41(2):195-216. PubMed ID: 24787293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycolytic genes in cancer cells are more than glucose metabolic regulators.
    Hu ZY; Xiao L; Bode AM; Dong Z; Cao Y
    J Mol Med (Berl); 2014 Aug; 92(8):837-45. PubMed ID: 24906457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered Stra13 and Dec2 circadian gene expression in hypoxic cells.
    Guillaumond F; Lacoche S; Dulong S; Grechez-Cassiau A; Filipski E; Li XM; Lévi F; Berra E; Delaunay F; Teboul M
    Biochem Biophys Res Commun; 2008 May; 369(4):1184-9. PubMed ID: 18342625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-coding RNAs in the reprogramming of glucose metabolism in cancer.
    Shankaraiah RC; Veronese A; Sabbioni S; Negrini M
    Cancer Lett; 2018 Apr; 419():167-174. PubMed ID: 29366802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERRα metabolic nuclear receptor controls growth of colon cancer cells.
    Bernatchez G; Giroux V; Lassalle T; Carpentier AC; Rivard N; Carrier JC
    Carcinogenesis; 2013 Oct; 34(10):2253-61. PubMed ID: 23720198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondria in cancer: not just innocent bystanders.
    Frezza C; Gottlieb E
    Semin Cancer Biol; 2009 Feb; 19(1):4-11. PubMed ID: 19101633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.